Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin.

Sun Hong Yoo,Jung Hyun Kwon,Soon Woo Nam,Jong-Yul Lee,Young Woon Kim,Dong Jae Shim,Sung Won Lee,Jeong Won Jang

Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin.

2020

Sun Hong Yoo
Jung Hyun Kwon
Soon Woo Nam
Jong-Yul Lee
Young Woon Kim
Dong Jae Shim
Sung Won Lee
Jeong Won Jang

Transarterial chemoembolization using doxorubicin (TACE-DOX) is an effective therapy for advanced hepatocellular carcinoma (HCC). However, there are limited options for patients with TACE refractor...

Keywords:

Epirubicin
Refractory period
Hepatocellular carcinoma
Cisplatin
Medicine
Sorafenib
Doxorubicin
Internal medicine
Pathology
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations